Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

Peter T. Nelson(University of Kentucky), Irina Alafuzoff(Uppsala University), Eileen H. Bigio(Northwestern University), Constantin Bouras(University of Geneva), Heiko Braak(Universität Ulm), Nigel J. Cairns(Washington University in St. Louis), Rudolph J. Castellani(University of Maryland, Baltimore), Barbara J. Crain(Johns Hopkins University), Peter Davies(Albert Einstein College of Medicine), Kelly Del Tredici(Universität Ulm), Charles Duyckaerts, Matthew P. Frosch(Harvard University), Vahram Haroutunian(Icahn School of Medicine at Mount Sinai), Patrick R. Hof(Icahn School of Medicine at Mount Sinai), Christine M. Hulette(Duke University), Bradley T. Hyman(Harvard University), Takeshi Iwatsubo(The University of Tokyo), K. A. Jellinger, Gregory A. Jicha(University of Kentucky), Enikò Kövari(University of Geneva), Walter A. Kukull(University of Washington), James B. Leverenz(University of Washington), Seth Love(Frenchay Hospital), Ian R. Mackenzie(University of British Columbia), David Mann(University of Manchester), Eliezer Masliah(University of California San Diego), Ann C. McKee(Boston University), Thomas J. Montine(University of Washington), John C. Morris(Washington University in St. Louis), Julie A. Schneider(Rush University Medical Center), Joshua A. Sonnen(Rush University), Dietmar Rudolf Thal(Universität Ulm), John Q. Trojanowski(Institute on Aging), Juan C. Troncoso(Johns Hopkins University), Thomas Wısnıewskı(NYU Langone Health), Randall L. Woltjer(Oregon Health & Science University), Thomas G. Beach(Banner Sun Health Research Institute)
Journal of Neuropathology & Experimental Neurology
April 6, 2012
Cited by 2,072Open Access
Full Text

Abstract

Clinicopathologic correlation studies are critically important for the field of Alzheimer disease (AD) research. Studies on human subjects with autopsy confirmation entail numerous potential biases that affect both their general applicability and the validity of the correlations. Many sources of data variability can weaken the apparent correlation between cognitive status and AD neuropathologic changes. Indeed, most persons in advanced old age have significant non-AD brain lesions that may alter cognition independently of AD. Worldwide research efforts have evaluated thousands of human subjects to assess the causes of cognitive impairment in the elderly, and these studies have been interpreted in different ways. We review the literature focusing on the correlation of AD neuropathologic changes (i.e. β-amyloid plaques and neurofibrillary tangles) with cognitive impairment. We discuss the various patterns of brain changes that have been observed in elderly individuals to provide a perspective for understanding AD clinicopathologic correlation and conclude that evidence from many independent research centers strongly supports the existence of a specific disease, as defined by the presence of Aβ plaques and neurofibrillary tangles. Although Aβ plaques may play a key role in AD pathogenesis, the severity of cognitive impairment correlates best with the burden of neocortical neurofibrillary tangles.


Related Papers